Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ventyx Biosciences (VTYX)
NASDAQ:VTYX
Ventyx Biosciences (VTYX) Stock Price & Analysis
200 Followers
VTYX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.87 - $40.58
Previous Close$5.81
Volume2.20M
Average Volume (3M)4.43M
Market Cap
$343.96M
Enterprise Value$55.47M
Total Cash (Recent Filing)$300.82M
Total Debt (Recent Filing)$12.33M
Price to Earnings (P/E)-1.8
Beta0.53
Next Earnings
May 09, 2024EPS Estimate
-$0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.29
Shares Outstanding59,252,349
10 Day Avg. Volume1,397,924
30 Day Avg. Volume4,426,394
Standard Deviation0.53
R-Squared0.00136
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)1.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.30
Forecast
1Y Price Target
$11.71Price Target Upside112.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Ventyx Biosciences News
PremiumCompany Announcements
Ventyx Biosciences CBO Christopher Krueger Steps Down
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VTYX FAQ
What was Ventyx Biosciences’s price range in the past 12 months?
Ventyx Biosciences lowest stock price was $1.86 and its highest was $40.58 in the past 12 months.
What is Ventyx Biosciences’s market cap?
Currently, no data Available
When is Ventyx Biosciences’s upcoming earnings report date?
Ventyx Biosciences’s upcoming earnings report date is May 09, 2024 which is in 21 days.
How were Ventyx Biosciences’s earnings last quarter?
Ventyx Biosciences released its earnings results on Feb 27, 2024. The company reported -$0.79 earnings per share for the quarter, beating the consensus estimate of -$0.865 by $0.075.
Is Ventyx Biosciences overvalued?
According to Wall Street analysts Ventyx Biosciences’s price is currently Undervalued.
Does Ventyx Biosciences pay dividends?
Ventyx Biosciences does not currently pay dividends.
What is Ventyx Biosciences’s EPS estimate?
Ventyx Biosciences’s EPS estimate is -$0.68.
How many shares outstanding does Ventyx Biosciences have?
Ventyx Biosciences has 59,252,350 shares outstanding.
What happened to Ventyx Biosciences’s price movement after its last earnings report?
Ventyx Biosciences reported an EPS of -$0.79 in its last earnings report, beating expectations of -$0.865. Following the earnings report the stock price went up 28.43%.
Which hedge fund is a major shareholder of Ventyx Biosciences?
Among the largest hedge funds holding Ventyx Biosciences’s share is Graham Capital Management, L.P.. It holds Ventyx Biosciences’s shares valued at 1M.
---
Ventyx Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.71 (112.91% Upside)
$11.71 (112.91% Upside)
Blogger Sentiment
Neutral
VTYX Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.8%
Last 30 Days ▲ 3.1%
Last 30 Days ▲ 3.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.06%
12-Months-Change
Fundamentals
Return on Equity
-64.56%
Trailing 12-Months
Asset Growth
-24.56%
Trailing 12-Months
Company Description
Ventyx Biosciences
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
---
VTYX Earnings Call
Q2 2023
0:00 / 0:00
---
VTYX Stock 12 Months Forecast
Average Price Target
$11.71
▲(112.91% Upside)
Technical Analysis
Best Analysts Covering VTYX
1 Year
1 Year Success Rate
6/19 ratings generated profit
1 Year Average Return
-4.68%
reiterated a buy rating last month
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 31.58% of your transactions generating a profit, with an average return of -4.68% per trade.
---